(Q33904763)

English

Effects on quality of life, anti-cancer responses, breast conserving surgery and survival with neoadjuvant docetaxel: a randomised study of sequential weekly versus three-weekly docetaxel following neoadjuvant doxorubicin and cyclophosphamide in wom

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Effects on quality of life, anti-cancer responses, breast conserving surgery and survival with neoadjuvant docetaxel: a randomised study of sequential weekly versus three-weekly docetaxel following neoadjuvant doxorubicin and cyclophosphamide in wom (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Leslie G Walker

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Jennifer M Eremin

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Mark M Aloysius

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Wichai Vassanasiri

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Mary B Walker

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Mohamed El-Sheemy

6

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Ged Cowley

7

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Jeanette Beer

8

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Srila Samphao

9

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Janice Wiseman

10

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Jibril A Jibril

11

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

David Valerio

12

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

David J Clarke

13

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Mujahid Kamal

14

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Gerald W Thorpe

15

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Karin Baria

16

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Oleg Eremin

17

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

language of work or name

0 references

publication date

18 May 2011

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

179

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Overall survival benefit for weekly vs. three-weekly taxanes regimens in advanced breast cancer: A meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117815

5 July 2018

Weekly paclitaxel in the adjuvant treatment of breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117815

5 July 2018

Evidence-based use of neoadjuvant taxane in operable and inoperable breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117815

5 July 2018

Biostatistics 103: qualitative data - tests of independence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117815

5 July 2018

The validity of the Hospital Anxiety and Depression Scale. An updated literature review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117815

5 July 2018

Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117815

5 July 2018

Issues involved in research into the neoadjuvant treatment of breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117815

5 July 2018

Psychological, clinical and pathological effects of relaxation training and guided imagery during primary chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117815

5 July 2018

Primary chemotherapy for early breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117815

5 July 2018

Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117815

5 July 2018

The hospital anxiety and depression scale

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117815

5 July 2018

Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117815

5 July 2018

Comprehensive management of locally advanced breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117815

5 July 2018

Assessment of response to therapy in advanced breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117815

5 July 2018

Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-179

21 January 2018

Phase III randomized trial of doxorubicin and docetaxel versus doxorubicin and cyclophosphamide as primary medical therapy in women with breast cancer: an anglo-celtic cooperative oncology group study

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-179

21 January 2018

Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-179

21 January 2018

Maximized reduction of primary breast tumor size using preoperative chemotherapy with doxorubicin and docetaxel

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-179

21 January 2018

Weekly docetaxel in the treatment of elderly patients with advanced breast cancer: a Minnie Pearl Cancer Research Network phase II trial

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-179

21 January 2018

A multicentre, randomised phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-179

21 January 2018

Weekly paclitaxel improves pathologic complete remission in operable breast cancer when compared with paclitaxel once every 3 weeks

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-179

21 January 2018

Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-179

21 January 2018

Meaningful change in cancer-specific quality of life scores: differences between improvement and worsening.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-179

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-179

21 January 2018

Weekly paclitaxel in the adjuvant treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-179

21 January 2018

Canalicular stenosis secondary to weekly versus every-3-weeks docetaxel in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-179

21 January 2018

Canalicular stenosis secondary to docetaxel (taxotere): a newly recognized side effect

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-179

21 January 2018

Weekly docetaxel in metastatic breast cancer patients: no superior benefits compared to three-weekly docetaxel

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117815

29 October 2018

Weekly docetaxel as neoadjuvant chemotherapy for stage II and III breast cancer: efficacy and correlation with biological markers in a phase II, multicenter study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117815

29 October 2018

Neoadjuvant docetaxel in breast cancer: 3-year survival results from the Aberdeen trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117815

29 October 2018

Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute

1 reference

https://pubmed.ncbi.nlm.nih.gov/21592370

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Docetaxel administered on a weekly basis for metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21592370

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale

1 reference

https://pubmed.ncbi.nlm.nih.gov/21592370

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21592370

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21592370

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer:National Surgical Adjuvant Breast and Bowel Project Protocol B-27

1 reference

https://pubmed.ncbi.nlm.nih.gov/21592370

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective study of incidence and severity of epiphora and canalicular stenosis in patients with metastatic breast cancer receiving docetaxel

1 reference

https://pubmed.ncbi.nlm.nih.gov/21592370

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2407-11-179

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33904763&oldid=2195965567"